Back to Search

DANIEL MORGENSZTERN, MD

MD

Medical Oncology Physician

NPI: 1154379915IndividualAccepts Medicare

Specialties, Licenses & Credentials

Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

2013021823(MO)

Education

OTHER

Class of 1995

Research & Publications (20)

Gene expression profiling in diffuse large B-cell lymphoma.
PMID 17454624·Leuk Lymphoma·2007
6-review
Adjuvant chemotherapy for lung cancer: cisplatin doublets only?
PMID 18377846·J Natl Compr Canc Netw·2008
8-other
Is there a role for cetuximab in non small cell lung cancer?
PMID 17671149·Clin Cancer Res·2007
6-review
Second-line therapy for esophageal cancer.
PMID 17555397·Expert Rev Anticancer Ther·2007
6-review
Prognostic biomarkers in diffuse large B-cell lymphoma.
PMID 16418498·J Clin Oncol·2006
6-review
PI3K/Akt/mTOR pathway as a target for cancer therapy.
PMID 16096426·Anticancer Drugs·2005
6-review
Molecular prognostic factors in diffuse large B-cell lymphoma.
PMID 15967080·Curr Treat Options Oncol·2005
6-review
Non-Hodgkin's lymphoma in the microarray era.
PMID 15453930·Clin Lymphoma·2004
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
4921 PARKVIEW PL, DIV IM MEDICAL ONCOLOGY, STE 7A, 7B, 7C
SAINT LOUIS, MO 63110

Quick Facts

NPI
1154379915
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
31
Publications
20

Are you this provider?

Claim Your Profile